NEW YORK – Leica Biosystems and Sectra announced on Monday a collaboration to develop an integrated clinical pathology solution with an eventual intended submission to the US Food and Drug Administration for 510(k) clearance.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.